US › Healthcare

InspireMD Inc (NSPR)

US · Healthcare · Medical Devices

$0.72+5.71%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$3.4M
Revenue YoY
+122.2%
Net profit
$289,000
Profit YoY
+102.6%
EPS
$-0.16
EPS estimate
$-0.18
Net margin
8.5%

EPS came in at -0.16 against a street estimate of -0.18 — a beat of 11.1%.

Key statistics

Market cap
$30.4M
Forward P/E
11.7
P/B
0.70
Book value
$0.93
EPS (TTM)
$-0.70
52-week high
$2.93
52-week low
$0.63
50-day MA
$0.77
200-day MA
$1.48
Beta
0.78

Analyst view

Analysts rate InspireMD Inc a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $3.67.

Shareholding

Insiders
19.82%
Institutions
49.85%

Largest institutional holders

FundStake
Rosalind Advisors, Inc.8.33%
Nantahala Capital Management, LLC7.20%
Aberdeen Group PLC6.77%
Orbimed Advisors, LLC6.68%
Parkman Healthcare Partners LLC5.15%
Velan Capital Investment Management LP4.48%
Marshall Wace Asset Management Ltd3.97%
Soleus Capital Management, L.P.2.23%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for InspireMD Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.